Management of patients with herpes-associated recurrent vulvovaginal candidiasis
https://doi.org/10.51523/2708-6011.2021-18-4-10
Abstract
Objective. To develop a diagnostic algorithm, a rational method of treatment, and principles of preconception care in women with herpes-associated recurrent vulvovaginal candidiasis (RVVC).
Materials and methods. We examined 68 patients with herpes-associated RVVC and 20 gynecologically healthy women.
Results. It has been found that in RVVC it is necessary to study vaginal swab culture with the determination of the microorganism and its biofilm-forming ability in combination with viral DNA detection by the polymerase chain reaction (PCR) in vaginal secretion, determination of the IgG titer to the herpes simplex virus (HSV), the avidity index to HSV I and II. In the presence of laboratory-confirmed RVVC and HSV infection, it is necessary to assume the presence of an atypical course of HSV infection followed by complex antiviral and antimycotic therapy.
Conclusion. The use of the developed algorithm of diagnostic and treatment interventions as preconception care makes it possible to address symptoms, reduce relapse rates and extend a non-relapse interval, prepare women with the mixed-infection for favorable pregnancy outcomes.
About the Authors
A. V. Kovaleva
Vitebsk State Order of People’s Friendship Medical University
Belarus
Belarus
Anastasia V. Kovaleva, Assistant Lecturer at the Department of Obstetrics and Gynecology
Vitebsk
E. V. Kovalev
Vitebsk State Order of People’s Friendship Medical University
Belarus
Belarus
Egor V. Kovalev, PhD (Med), Assistant Lecturer at
the Department of Obstetrics and Gynecology
Vitebsk
I. M. Arestova
Vitebsk State Order of People’s Friendship Medical University
Belarus
Belarus
Irina M. Arestova, DMedSc, Professor at the Department of Obstetrics and Gynecology
Vitebsk
References
1. Tazina TV. A modern approach to the treatment of mixed vulvovaginal infections. Russian Journal of Woman and Child Health. 2021;(2):144-148. (In Russ.). DOI: https://doi.org/10.32364/2618-8430-2021-4-2-144-148
2. Khashukoeva AZ, Safonina MS, Andreasyan GO, Myasoutova AI, Overko AV. Therapeutic approaches in the treatment of vulvovaginal candidiasis. Meditsinskiy sovet = Medical Council. 2020;(13):138-146. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2020-13-138-146
3. Bondarenko KR. Cervical vaginal mixed infections in gynecology: unresolved therapeutic issues. Russian Journal of Woman and Child Health. 2019;2(3):194-199. (In Russ.) DOI: https://doi.org/10.32364/2618-8430-2019-2-3-194-199
4. Swidsinski A, Guschin A, Tang Q. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. Am J Obstet Gynecol. 2019;220(1):1-91. DOI: https://doi.org/10.1016/j.ajog.2018.10.023
5. Mendling W. Normal and abnormal vaginal microbiota. Journal of Laboratory Medicine. 2016;40(4):239-246. DOI: https://doi.org/10.1515/labmed-2016-0011
6. Savicheva AM, Shipitsyna EV. Vaginal microbiota in bacterial vaginosis. Aspects of diagnosis and therapy. Meditsinskiy sovet = Medical Council. 2014;(9):90-95. (In Russ.) DOI: https://doi.org/10.21518/2079-701X-2014-9-90-95
7. Khryanin AA, Reshetnikov OV. Modern perspectives of the treatment of genital herpes. Meditsinskiy sovet = Medical Council. 2019;(13):80-84. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2019-13-80-84
8. Looker KJ, Garnett GP, Schmid GP. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ. 2008;86(10):805-812 . DOI: https://doi.org/10.2471/blt.07.046128
9. Dovletkhanova ER, Abakarova PR. Modern possibilities for the diagnosis and treatment of vulvovaginal candidiasis (to help the practitioner). Meditsinskiy sovet = Medical Council. 2019;(13):42-48. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2019-13-42-48
10. Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15-21. DOI: https://doi.org/10.1016/j.ajog.2015.06.067
11. Dvoriankova EV, Sakaniia LR, Babaev OR, Shahzadov VV, Korsunskaya IM. Features of genital herpes in women. Gynecology. 2018;20(4):55-59. (In Russ.). DOI: https://doi.org/10.26442/2079-5696_2018.4.55-59
12. Karapetyan T, Ankirskaya A, Muravyova V. Effective therapy of Candida vaginitis. Meditsinskiy sovet = Medical Council. 2014;(7):58-61. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2014-7-58-61
13. Murakov SV, Vladimirova EV, Kovalyk VP, Markova YA, Vladimirov AA, Stromskaya UA, et al. Vulvovaginal candidiasis: topical aspects of etiopathogenesis, diagnosis and treatment. Russian Medical Review. 2020;(10):625-631. (In Russ.). DOI: https://doi.org/10.32364 / 2587-6821-2020-4-10-625-631
14. Serov VN, Buralkina NA, Borisenko MYu, Mamedova FS. The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis. Meditsinskiy sovet = Medical Council. 2016;(2):60-63. (In Russ.) DOI: https://doi.org/10.21518/2079-701X-2016-2-60-6
15. Lyubasovskaya LA, Muravieva VV, Shabanova NE, Priputnevich TV. Treatment of recurrent vulvovaginal candidiasis -systemic or topical therapy. Meditsinskiy sovet = Medical Council. 2020;(13):124-129. (In Russ.). DOI: https://doi.org/10.21518/2079-701X-2020-13-124-129
Review
For citations:
Kovaleva A.V., Kovalev E.V., Arestova I.M. Management of patients with herpes-associated recurrent vulvovaginal candidiasis. Health and Ecology Issues. 2021;18(4):74-82. (In Russ.) https://doi.org/10.51523/2708-6011.2021-18-4-10
Views: 410
Email this article 